Brian Adams is Chief Legal Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 52,500 shares of KYMR, which is worth approximately $2.28 Million. The most recent transaction as insider was on Sep 03, 2025, when has been sold 52,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
n/a 3M change
n/a 12M change
Total Value Held $2.28 Million

Brian Adams Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2025
BUY
Grant, award, or other acquisition
-
52,500 Added 50.0%
52,500 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
BA

Brian Adams

Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR